KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Total Liabilities (2016 - 2025)

Evolent Health (EVH) has 11 years of Total Liabilities data on record, last reported at $1.6 billion in Q3 2025.

  • For Q3 2025, Total Liabilities rose 10.13% year-over-year to $1.6 billion; the TTM value through Sep 2025 reached $1.6 billion, up 10.13%, while the annual FY2024 figure was $1.4 billion, 5.66% down from the prior year.
  • Total Liabilities reached $1.6 billion in Q3 2025 per EVH's latest filing, up from $1.3 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.6 billion in Q3 2025 and bottomed at -$614.2 million in Q2 2021.
  • Average Total Liabilities over 5 years is $1.0 billion, with a median of $1.4 billion recorded in 2024.
  • Peak YoY movement for Total Liabilities: crashed 188.8% in 2022, then surged 340.13% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $725.8 million in 2021, then surged by 31.97% to $957.9 million in 2022, then skyrocketed by 49.73% to $1.4 billion in 2023, then dropped by 5.66% to $1.4 billion in 2024, then increased by 19.09% to $1.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $1.6 billion in Q3 2025, $1.3 billion in Q2 2025, and $1.5 billion in Q1 2025.